Novo Nordisk accelerates the output of its CEO in the face of the “market challenges”
Danish pharmaceuticals Novo Nordisk, owner of the treatments against obesity 'Ozempic' and 'Wegovy', announced this Friday The departure of your ...
Danish pharmaceuticals Novo Nordisk, owner of the treatments against obesity 'Ozempic' and 'Wegovy', announced this Friday The departure of your ...
Being the pioneer in something can be great success, but this success does not have to be eternal. The Danish ...
CaixaBank is among the suitors who explore a possible acquisition of Novo Bancothe Portuguese bank backed by Lone Star Funds ...
Novo Nordisk will sell Wegovy in the United States to unabled patients or patients eligible with insurance They have no ...
Real Madrid, X - Manchester City, X The white team Show comments {"Allowcomment": "ALLOWED", "ARTICLEID": "ARTICLE-10401059", "URL": "https: //admin.lavanguardia.com /view ...
Lone Star decide your exit plan New Bank. The American fund is selecting advisors to explore a possible sale with ...
The General Supervisory Board of Novo Banco, an entity that emerged in 2014 after the bankruptcy of BES and is ...
Nordisk ha made public the conclusions of the clinical trial of its new candidate drug against obesity and the results ...